Does the media favor COO or BDX?

In the previous week, Becton, Dickinson and Company had 13 more articles in the media than Cooper Companies. MarketBeat recorded 25 mentions for Becton, Dickinson and Company and 12 mentions for Cooper Companies. Becton, Dickinson and Company's average media sentiment score of 1.22 beat Cooper Companies' score of 0.50 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cooper Companies 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Neutral Becton, Dickinson and Company 19 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor HSIC or BDX?

In the previous week, Becton, Dickinson and Company had 9 more articles in the media than Henry Schein. MarketBeat recorded 25 mentions for Becton, Dickinson and Company and 16 mentions for Henry Schein. Becton, Dickinson and Company's average media sentiment score of 1.22 beat Henry Schein's score of 0.77 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 8 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Becton, Dickinson and Company 19 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor BDX or CAH?

In the previous week, Becton, Dickinson and Company had 22 more articles in the media than Cardinal Health. MarketBeat recorded 25 mentions for Becton, Dickinson and Company and 3 mentions for Cardinal Health. Becton, Dickinson and Company's average media sentiment score of 1.22 beat Cardinal Health's score of 1.00 indicating that Becton, Dickinson and Company is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Becton, Dickinson and Company 19 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cardinal Health 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to BDX or DVA?

In the previous week, Becton, Dickinson and Company had 20 more articles in the media than DaVita. MarketBeat recorded 25 mentions for Becton, Dickinson and Company and 5 mentions for DaVita. Becton, Dickinson and Company's average media sentiment score of 1.22 beat DaVita's score of 0.89 indicating that Becton, Dickinson and Company is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Becton, Dickinson and Company 19 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DaVita 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Becton, Dickinson and Company (BDX) Competitors

$145.17 +0.74 (+0.51%)

As of 12:10 PM Eastern

Compare

BDX vs. COO, HSIC, AMN, CAH, and DVA

Should you buy Becton, Dickinson and Company stock or one of its competitors? MarketBeat compares Becton, Dickinson and Company with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Becton, Dickinson and Company include Cooper Companies (COO), Henry Schein (HSIC), AMN Healthcare Services (AMN), Cardinal Health (CAH), and DaVita (DVA). These companies are all part of the "medical" sector.

How does Becton, Dickinson and Company compare to Cooper Companies?

Cooper Companies (NASDAQ:COO) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, media sentiment, valuation and institutional ownership.

Becton, Dickinson and Company has higher revenue and earnings than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.09B	2.86	$374.90M	$2.02	29.75
Becton, Dickinson and Company	$22.23B	1.80	$1.68B	$3.95	36.75

Cooper Companies has a net margin of 9.67% compared to Becton, Dickinson and Company's net margin of 5.33%. Becton, Dickinson and Company's return on equity of 15.37% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cooper Companies	9.67%	10.34%	6.93%
Becton, Dickinson and Company	5.33%	15.37%	7.11%

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by company insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Cooper Companies presently has a consensus target price of $88.07, suggesting a potential upside of 46.57%. Becton, Dickinson and Company has a consensus target price of $183.64, suggesting a potential upside of 26.50%. Given Cooper Companies' stronger consensus rating and higher probable upside, research analysts plainly believe Cooper Companies is more favorable than Becton, Dickinson and Company.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	1 Sell rating(s)	7 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.53
Becton, Dickinson and Company	1 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.38

In the previous week, Becton, Dickinson and Company had 13 more articles in the media than Cooper Companies. MarketBeat recorded 25 mentions for Becton, Dickinson and Company and 12 mentions for Cooper Companies. Becton, Dickinson and Company's average media sentiment score of 1.22 beat Cooper Companies' score of 0.50 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cooper Companies	2 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral
Becton, Dickinson and Company	19 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cooper Companies has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market. Comparatively, Becton, Dickinson and Company has a beta of 0.22, meaning that its stock price is 78% less volatile than the broader market.

Summary

Becton, Dickinson and Company beats Cooper Companies on 9 of the 17 factors compared between the two stocks.

How does Becton, Dickinson and Company compare to Henry Schein?

Henry Schein (NASDAQ:HSIC) and Becton, Dickinson and Company (NYSE:BDX) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

Becton, Dickinson and Company has higher revenue and earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.66	$398M	$3.31	22.93
Becton, Dickinson and Company	$22.23B	1.80	$1.68B	$3.95	36.75

In the previous week, Becton, Dickinson and Company had 9 more articles in the media than Henry Schein. MarketBeat recorded 25 mentions for Becton, Dickinson and Company and 16 mentions for Henry Schein. Becton, Dickinson and Company's average media sentiment score of 1.22 beat Henry Schein's score of 0.77 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	8 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Becton, Dickinson and Company	19 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Henry Schein has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market. Comparatively, Becton, Dickinson and Company has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market.

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Becton, Dickinson and Company has a net margin of 5.33% compared to Henry Schein's net margin of 2.95%. Henry Schein's return on equity of 15.44% beat Becton, Dickinson and Company's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.95%	15.44%	5.53%
Becton, Dickinson and Company	5.33%	15.37%	7.11%

Henry Schein currently has a consensus price target of $86.83, suggesting a potential upside of 14.39%. Becton, Dickinson and Company has a consensus price target of $183.64, suggesting a potential upside of 26.50%. Given Becton, Dickinson and Company's stronger consensus rating and higher possible upside, analysts clearly believe Becton, Dickinson and Company is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36
Becton, Dickinson and Company	1 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.38

Summary

Becton, Dickinson and Company beats Henry Schein on 12 of the 16 factors compared between the two stocks.

How does Becton, Dickinson and Company compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Becton, Dickinson and Company (NYSE:BDX) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, media sentiment, risk, profitability, analyst recommendations and dividends.

AMN Healthcare Services presently has a consensus target price of $25.29, suggesting a potential downside of 13.64%. Becton, Dickinson and Company has a consensus target price of $183.64, suggesting a potential upside of 26.50%. Given Becton, Dickinson and Company's stronger consensus rating and higher possible upside, analysts clearly believe Becton, Dickinson and Company is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22
Becton, Dickinson and Company	1 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.38

Becton, Dickinson and Company has a net margin of 5.33% compared to AMN Healthcare Services' net margin of -0.95%. AMN Healthcare Services' return on equity of 18.01% beat Becton, Dickinson and Company's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	-0.95%	18.01%	5.19%
Becton, Dickinson and Company	5.33%	15.37%	7.11%

AMN Healthcare Services has a beta of 0.44, indicating that its stock price is 56% less volatile than the broader market. Comparatively, Becton, Dickinson and Company has a beta of 0.22, indicating that its stock price is 78% less volatile than the broader market.

AMN Healthcare Services pays an annual dividend of $1.20 per share and has a dividend yield of 4.1%. Becton, Dickinson and Company pays an annual dividend of $4.20 per share and has a dividend yield of 2.9%. AMN Healthcare Services pays out -137.9% of its earnings in the form of a dividend. Becton, Dickinson and Company pays out 106.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Becton, Dickinson and Company has increased its dividend for 53 consecutive years. AMN Healthcare Services is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Becton, Dickinson and Company had 11 more articles in the media than AMN Healthcare Services. MarketBeat recorded 25 mentions for Becton, Dickinson and Company and 14 mentions for AMN Healthcare Services. Becton, Dickinson and Company's average media sentiment score of 1.22 beat AMN Healthcare Services' score of 0.17 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Becton, Dickinson and Company	19 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Becton, Dickinson and Company has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$3.42B	0.33	-$95.70M	-$0.87	N/A
Becton, Dickinson and Company	$22.23B	1.80	$1.68B	$3.95	36.75

Summary

Becton, Dickinson and Company beats AMN Healthcare Services on 13 of the 19 factors compared between the two stocks.

How does Becton, Dickinson and Company compare to Cardinal Health?

Becton, Dickinson and Company (NYSE:BDX) and Cardinal Health (NYSE:CAH) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, analyst recommendations and valuation.

In the previous week, Becton, Dickinson and Company had 22 more articles in the media than Cardinal Health. MarketBeat recorded 25 mentions for Becton, Dickinson and Company and 3 mentions for Cardinal Health. Becton, Dickinson and Company's average media sentiment score of 1.22 beat Cardinal Health's score of 1.00 indicating that Becton, Dickinson and Company is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Becton, Dickinson and Company	19 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cardinal Health	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Becton, Dickinson and Company currently has a consensus target price of $183.64, suggesting a potential upside of 26.50%. Cardinal Health has a consensus target price of $241.80, suggesting a potential upside of 23.05%. Given Becton, Dickinson and Company's higher probable upside, equities research analysts clearly believe Becton, Dickinson and Company is more favorable than Cardinal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Becton, Dickinson and Company	1 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.38
Cardinal Health	0 Sell rating(s)	2 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.94

Becton, Dickinson and Company has a beta of 0.22, meaning that its stock price is 78% less volatile than the broader market. Comparatively, Cardinal Health has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market.

Becton, Dickinson and Company has higher earnings, but lower revenue than Cardinal Health. Cardinal Health is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Becton, Dickinson and Company	$22.23B	1.80	$1.68B	$3.95	36.75
Cardinal Health	$250.74B	0.18	$1.56B	$6.54	30.05

87.0% of Becton, Dickinson and Company shares are held by institutional investors. Comparatively, 87.2% of Cardinal Health shares are held by institutional investors. 0.4% of Becton, Dickinson and Company shares are held by insiders. Comparatively, 0.1% of Cardinal Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Becton, Dickinson and Company pays an annual dividend of $4.20 per share and has a dividend yield of 2.9%. Cardinal Health pays an annual dividend of $2.06 per share and has a dividend yield of 1.0%. Becton, Dickinson and Company pays out 106.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cardinal Health pays out 31.5% of its earnings in the form of a dividend. Becton, Dickinson and Company has raised its dividend for 53 consecutive years and Cardinal Health has raised its dividend for 29 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Becton, Dickinson and Company has a net margin of 5.33% compared to Cardinal Health's net margin of 0.62%. Becton, Dickinson and Company's return on equity of 15.37% beat Cardinal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Becton, Dickinson and Company	5.33%	15.37%	7.11%
Cardinal Health	0.62%	-92.61%	4.46%

Summary

Becton, Dickinson and Company beats Cardinal Health on 12 of the 20 factors compared between the two stocks.

How does Becton, Dickinson and Company compare to DaVita?

Becton, Dickinson and Company (NYSE:BDX) and DaVita (NYSE:DVA) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability, analyst recommendations and media sentiment.

Becton, Dickinson and Company has a beta of 0.22, meaning that its stock price is 78% less volatile than the broader market. Comparatively, DaVita has a beta of 0.91, meaning that its stock price is 9% less volatile than the broader market.

Becton, Dickinson and Company currently has a consensus price target of $183.64, suggesting a potential upside of 26.50%. DaVita has a consensus price target of $199.17, suggesting a potential upside of 2.47%. Given Becton, Dickinson and Company's higher probable upside, research analysts clearly believe Becton, Dickinson and Company is more favorable than DaVita.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Becton, Dickinson and Company	1 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.38
DaVita	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.38

In the previous week, Becton, Dickinson and Company had 20 more articles in the media than DaVita. MarketBeat recorded 25 mentions for Becton, Dickinson and Company and 5 mentions for DaVita. Becton, Dickinson and Company's average media sentiment score of 1.22 beat DaVita's score of 0.89 indicating that Becton, Dickinson and Company is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Becton, Dickinson and Company	19 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DaVita	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Becton, Dickinson and Company has higher revenue and earnings than DaVita. DaVita is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Becton, Dickinson and Company	$22.23B	1.80	$1.68B	$3.95	36.75
DaVita	$13.64B	0.91	$746.80M	$10.78	18.03

DaVita has a net margin of 5.65% compared to Becton, Dickinson and Company's net margin of 5.33%. Becton, Dickinson and Company's return on equity of 15.37% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Becton, Dickinson and Company	5.33%	15.37%	7.11%
DaVita	5.65%	-270.37%	4.87%

87.0% of Becton, Dickinson and Company shares are owned by institutional investors. Comparatively, 90.1% of DaVita shares are owned by institutional investors. 0.4% of Becton, Dickinson and Company shares are owned by company insiders. Comparatively, 1.5% of DaVita shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Becton, Dickinson and Company beats DaVita on 10 of the 16 factors compared between the two stocks.

Get Becton, Dickinson and Company News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BDX vs. The Competition

Export

Metric	Becton, Dickinson and Company	MED/DENTAL Industry	Medical Sector	NYSE Exchange
Market Cap	$40.00B	$14.22B	$6.26B	$23.13B
Dividend Yield	2.85%	1.21%	2.69%	4.09%
P/E Ratio	36.75	17.14	22.35	31.16
Price / Sales	1.80	2.08	555.60	14.72
Price / Cash	6.30	13.42	42.31	24.78
Price / Book	1.64	3.19	9.82	4.68
Net Income	$1.68B	$534.24M	$3.56B	$1.07B
7 Day Performance	-1.50%	-1.07%	-1.16%	-0.38%
1 Month Performance	-2.84%	4.88%	3.85%	0.52%
1 Year Performance	-14.98%	-3.03%	27.33%	25.86%

Becton, Dickinson and Company Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BDX Becton, Dickinson and Company	4.7873 of 5 stars	$145.17 +0.5%	$183.64 +26.5%	-14.9%	$40.00B	$22.23B	36.75	72,000	Positive News
COO Cooper Companies	4.0847 of 5 stars	$60.19 -1.7%	$88.07 +46.3%	-11.2%	$11.74B	$4.09B	29.80	15,000	Trending News Upcoming Earnings Analyst Forecast
HSIC Henry Schein	3.2715 of 5 stars	$76.40 -0.2%	$86.83 +13.7%	+9.3%	$8.70B	$13.18B	23.08	25,000
AMN AMN Healthcare Services	1.6263 of 5 stars	$29.47 +1.7%	$25.29 -14.2%	+48.2%	$1.14B	$2.73B	N/A	2,664	Analyst Revision Gap Down
CAH Cardinal Health	4.789 of 5 stars	$195.33 -0.7%	$241.80 +23.8%	+25.6%	$45.75B	$222.58B	29.87	57,700

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:BDX) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Becton, Dickinson and Company (BDX) Competitors

BDX vs. COO, HSIC, AMN, CAH, and DVA

How does Becton, Dickinson and Company compare to Cooper Companies?

Summary

How does Becton, Dickinson and Company compare to Henry Schein?

Summary

How does Becton, Dickinson and Company compare to AMN Healthcare Services?

Summary

How does Becton, Dickinson and Company compare to Cardinal Health?

Summary

How does Becton, Dickinson and Company compare to DaVita?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BDX vs. The Competition

Becton, Dickinson and Company Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Becton, Dickinson and Company (BDX) Competitors

BDX vs. COO, HSIC, AMN, CAH, and DVA

How does Becton, Dickinson and Company compare to Cooper Companies?

Which has higher earnings and valuation, COO or BDX?

Is COO or BDX more profitable?

Do institutionals and insiders hold more shares of COO or BDX?

Do analysts recommend COO or BDX?

Does the media favor COO or BDX?

Which has more risk & volatility, COO or BDX?

Summary

How does Becton, Dickinson and Company compare to Henry Schein?

Which has preferable valuation and earnings, HSIC or BDX?

Does the media favor HSIC or BDX?

Which has more risk and volatility, HSIC or BDX?

Do institutionals & insiders hold more shares of HSIC or BDX?

Is HSIC or BDX more profitable?

Do analysts recommend HSIC or BDX?

Summary

How does Becton, Dickinson and Company compare to AMN Healthcare Services?

Do analysts rate AMN or BDX?

Is AMN or BDX more profitable?

Which has more risk & volatility, AMN or BDX?

Is AMN or BDX a better dividend stock?

Does the media prefer AMN or BDX?

Do insiders and institutionals believe in AMN or BDX?

Which has stronger earnings & valuation, AMN or BDX?

Summary

How does Becton, Dickinson and Company compare to Cardinal Health?

Does the media favor BDX or CAH?

Do analysts rate BDX or CAH?

Which has more risk and volatility, BDX or CAH?

Which has stronger valuation & earnings, BDX or CAH?

Do insiders & institutionals believe in BDX or CAH?

Is BDX or CAH a better dividend stock?

Is BDX or CAH more profitable?

Summary

How does Becton, Dickinson and Company compare to DaVita?

Which has more risk & volatility, BDX or DVA?

Do analysts rate BDX or DVA?

Does the media refer more to BDX or DVA?

Which has stronger valuation and earnings, BDX or DVA?

Is BDX or DVA more profitable?

Do insiders & institutionals have more ownership in BDX or DVA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BDX vs. The Competition

Becton, Dickinson and Company Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools